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1281in inﬂammatory and ﬁbrogenic pathways may be critically
involved in the pathogenesis of heart failure in elderly
subjects (5–7). Normal aging has also been associated with
increased interstitial ﬁbrosis that reduces the reserve capacity
of the heart to respond to stress (8). Moreover, animal
models of aging have also shown age-related alterations in
collagen deposition (9,10). Studies involving human subjects
and post-mortem examinations have documented increased
ﬁbrosis in the conduction system (11) and atria with aging,
but the true incidence of global myocardial ﬁbrosis that can
be expected in the general elderly population is not known.See page 1288
MOLLI = modiﬁed Look-
Locker inversion recovery
MR = magnetic resonanceEmerging experimental and clinical investigations hold
promise for the detection of myocardial ﬁbrosis derived
from noninvasive myocardial viability assessment by using
contrast-enhanced magnetic resonance (MR) imaging tech-
niques (12–14). Late gadolinium (Gd) enhancement MR
protocols use a T1-weighted inversion recovery–prepared fast
gradient echo with imaging performed 10 to 20 min after
the intravenous administration of an extracellular Gd-based
contrast agent (13). Late Gd enhancement CMR is based
on the difference of the principal tissue property, the longi-
tudinal spin-lattice relaxation time (T1), to generate the
signal contrast between the regional myocardial ﬁbrosis and
the normal myocardium. With this T1-weighted imaging
technique, infarcted regions in the myocardium, having
undergone scar formation with collagen deposition, have
a much slower washout rate of Gd-based contrast than
healthy myocardium, leading to markedly decreased T1
values (15).
Diffusely ﬁbrotic myocardium accumulates contrast in
a fashion similar to regional scarring, but calculation of the
T1 time is required for its quantiﬁcation. The MR imaging
techniques, known generically as T1 mapping (16–18),
directly measure the longitudinal magnetization recovery
(T1) relaxation times of the myocardium at high resolution.
T1 mapping enables the characterization of myocardial
structure on a scale, which may be standardized and that is
particularly useful in evaluating diffusely ﬁbrotic myocar-
dium. CMR T1 measurements have also been strongly
correlated with myocardial ﬁbrosis by histological assessment
of collagen content (16,19). A novel imaging technique,
the modiﬁed Look-Locker inversion recovery (MOLLI)
sequence developed by Messroghli et al. (17,20–23),
allows the measurement of myocardial T1 within 1 breath
hold. MOLLI has been proven to be a reproducible
method for quantitative tissue characterization and
measurement of myocardial ﬁbrosis.
In the current study, we used the MOLLI T1 mapping
MR imaging technique to characterize myocardial ﬁbrosis
in a large epidemiological population-based study and
to determine whether the T1-mapping–derived indiceswere related to the human aging
process. The target study pop-
ulation included 1,231 male and
female participants of the MESA
(Multi-Ethnic Study of Athero-
sclerosis) (24) age 54 to 93 years
with T1-mapping measurements
obtained between 2010 and 2012
as part of the ﬁfth study exami-
nation of MESA.Methods
Study population. MESA was
initiated by the National Heart,
Lung, and Blood Institute in 2000 to further understanding
of the pathogenesis of atherosclerosis and other cardiovas-
cular diseases. In the longitudinal follow-up of the ﬁfth
examination of each subject in the MESA study from April
2010 to February 2012, a total of 3,015 participants under-
went CMR imaging. Of these, 1,391 from 5 clinical sites
(Johns Hopkins University, Baltimore, Maryland; University
of Minnesota, Minneapolis, Minnesota; Northwestern
University, Chicago, Illinois; Wake Forest University,
Winston-Salem, North Carolina; and University of
California, Los Angeles, Los Angeles, California) received
T1 mapping by using the MOLLI sequence. From these
subjects, 1,231 studies with no ﬁndings of myocardial scar
were included in the current analyses. Institutional review
boards at each center approved the study protocol, and all
participants gave written informed consent.
Study procedures: CMR imaging. MESA participants
without contraindications underwent CMR examinations by
using 1.5-T scanners (Avanto and Espree, Siemens Medical
Systems, Erlangen, Germany) with a 6-channel anterior
phased array torso coil and corresponding posterior coil
elements. LV function, dimensions, and myocardial mass
were assessed by a cine steady-state free precession sequence.
Twelve short axis slices, one 4-chamber view, and one
2-chamber view were acquired. Participants undergoing
CMR scans were screened for Gd eligibility. The major
inclusion criteria were the glomerular ﬁltration rates (GFRs).
Participants with a GFR 45 ml/min (60 ml/min for the
site at Northwestern University) and with no history of
allergic reaction to contrast agents were qualiﬁed to receive
Gd. Delayed contrast enhancement images were obtained 15
min after an intravenous bolus injection of Gd–diethylene
triamine pentaacetic acid (0.15 mmol/kg [Magnevist, Bayer
Healthcare Pharmaceuticals, Montville, New Jersey]) to
identify regional ﬁbrosis. Twelve short-axis slices, 1 hori-
zontal long axis, and 1 vertical long axis at the same posi-
tions as the LV function cine images were acquired.
For evaluation of diffuse ﬁbrosis, 1 short axis pre-contrast
MOLLI image at the mid-slice position was acquired,
repeated at 12 and 25 min after contrast injection. The
timing was chosen to be comparable with previous studies
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CMR protocol. The MOLLI sequence acquired a set of
11 source images in 17 heartbeats. It consisted of 3 con-
secutively inversion recovery–prepared electrocardiography-
synchronized Look-Locker trains. Each of the 3 trains
began with an inversion pulse at speciﬁc inversion time
(T1 ¼ 100, 200, and 350 ms), after which multiple single-
shot, steady-state free precession images were acquired in
consecutive heartbeats. All images were acquired with the
same trigger delay time in end diastole. The exact scanning
parameters were as follows: ﬂip angle¼ 35; repetition time¼
2.2 ms; echo time ¼ 1.1 ms; ﬁeld of view ¼ 360  360 mm;
matrix ¼ 192  183; slice thickness ¼ 8 mm; generalized
autocalibrating partially parallel acquisitions factor¼ 2.
Data and statistical analysis. T1 maps were constructed
ofﬂine by using MASS research software (Department of
Radiology, Leiden University Medical Center, Leiden, the
Netherlands). A 3-parameter curve ﬁt of the MOLLI source
images according to the Levenberg-Marquardt algorithm
were performed with automatic calculation of T1 values for
each pixel. On each T1 map (pre-contrast and post-
contrast), a region of interest was manually drawn around
the core myocardium to exclude the blood pool and
epicardial fat to calculate the myocardial T1 time for each
subject. The partition coefﬁcient was determined by the
slope of the linear relationship of (1/T1myo vs. 1/T1blood) at 3
time points. Fraction of extracellular volume (ECV [%]) was
derived accounting for the hematocrit level (ECV ¼ 100 
partition coefﬁcient  [1 – hematocrit]). The Gd clearance
rate (DT1/Dt [ms/min]) was also calculated by subtracting
the T1 changes of the 2 post-contrast time points divided by
the acquisition time difference. Values were all expressed as
mean  SD. Univariable linear regression analyses were
performed to determine if the T1 indices were subject to
a mild systematic heart rate dependency (17).
The cohort was stratiﬁed according to sex in all analyses.
The 10-year risk of all coronary heart disease events
was estimated by using the Framingham equation (27).
Smoking, diabetes, hypertension (systolic/diastolic blood
pressure 140/90 mm Hg), and metabolic syndrome
(deﬁned according to National Cholesterol Education
Program guidelines) (28) were treated as binary variables
(yes/no) and compared between groups (men/women) by
using the chi-square test. For global cardiac function, LV
ejection fraction as well as the LV myocardial mass to
volume ratio were used as dependent variables. Sex-speciﬁc
distributions of T1 indices were categorized into quartiles
across subjects age 54 to 93 years in 10-year increments and
reported as mean  SD. To determine the association to the
aforementioned measured/calculated T1 indices, age was
treated as a continuous variable. Linear regressions with
multivariate adjustments for demographic characteristics
and risk factors were performed: model 1 adjusted for
race/ethnicity, weight, and heart rate; model 2 adjusted for
the variables in model 1 in addition to systolic blood pres-
sure, estimated GFR, and current smoking status; andmodel 3 included the variables from model 2 and also further
adjusted for smoking pack years, diabetes mellitus, taking
medication for hypertension, low-density lipoprotein, high-
density lipoprotein, LV mass to volume ratio, and highest
education level completed. Regression coefﬁcient (B) was
reported per 10 years’ change, and a p value <0.05 was used
for signiﬁcance for all analyses.
In addition to adjusting for major risk factors, we evalu-
ated the relationship of age and T1 indices for participants
with a body mass index (BMI) between 18 and 30 kg/m2,
never smokers, without hypertension or diabetes. Sex-
speciﬁc linear regressions with multivariate adjustments for
race, weight, estimated GFR, and heart rate were performed
in this “healthy” subcohort.
Results
Baseline characteristics of participants stratiﬁed according to
sex are summarized in Table 1; there were 625 women and
606 men with T1 mapping CMR measures. Age, BMI, and
the distributions of race/ethnicity did not differ between
women and men. The race/ethnic distribution globally was
51.7% white, 22.5% African American, 14.1% Hispanic,
and 11.7% Chinese American. Only 6.8% were current
smokers, 52.1% had hypertension, and 15% had diabetes.
Women had a slightly but signiﬁcantly higher heart rate than
men during CMR T1 mapping acquisitions (p ¼ 0.005).
Sex-related differences were shown in cardiac function
measurements, in which LVmass, volume, stroke volume (all
indexed according to body surface area), and mass-to-volume
ratio were greater in men than in women. However, the
ejection fraction was higher in women than in men.
Compared with women, men also had signiﬁcantly higher
total calcium scores as well as Framingham risk scores. Uni-
variable linear regression analyses did not show signiﬁcant
heart rate dependence for any of the T1 indices.
All T1 indices were signiﬁcantly different between women
and men, except the Gd clearance rate (DT1/Dt). Hemato-
crit was not available for some MESA participants because
of the logistics of handling laboratory specimens in 2
recruiting centers. Women had signiﬁcantly higher pre-
contrast T1 values, partition coefﬁcient, and ECV, as well as
lower post-contrast T1 times, compared with men. Table 2
displays the sex dependence of mean  SD T1 indices
according to age quartiles. The box plots in Figure 1
demonstrate the mean partition coefﬁcient and ECV in
each age category stratiﬁed according to sex. The partition
coefﬁcient increased signiﬁcantly with age quartiles for men
(p trend <0.001), but it remained relatively intact for
women (p trend ¼ 0.36). Women had signiﬁcantly higher
partition coefﬁcients than men in the ﬁrst and the second
quartiles (p < 0.01 for both). However, partition coefﬁcients
reached the same level for women and men in the third
quartile (p ¼ 0.996) and tended to be lower but not statis-
tically signiﬁcant for women in the last quartile (p ¼ 0.356).
When taking into account the hematocrit in the calculation
Table 1 Characteristics of the Study Population
Women
(n ¼ 625)
Men
(n ¼ 606) p Value
Age (yrs) 67  9 67  9 0.94
Height (cm) 160  6.6 174  7.5 <0.001
Weight (lb) 161  36 188  35 <0.001
BMI (kg/m2) 28  6 28  5 0.24
White/African/Chinese/Hispanic (%) 54/23/11/12 50/22/12/16 0.13
Heart rate (beats/min) 65.3  9.5 63.8  10 0.005
Systolic blood pressure (mm Hg) 122  20 121  18 0.49
Diastolic blood pressure (mm Hg) 65  9 71  9 <0.001
Current smokers 41 (6.6) 43 (7.1) <0.001
Hypertension 343 (54.9) 298 (49.2) 0.045
Diabetes 87 (13.9) 98 (16.2) 0.002
Metabolic syndrome* 233 (37.3) 182 (30) 0.001
HDL cholesterol (mg/dl) 60.2  16.9 49.1  13.1 <0.001
LDL cholesterol (mg/dl) 110.8  31.2 100.6  30.4 <0.001
Total cholesterol (mg/dl) 193.2  34.6 171.5  34 <0.001
Triglycerides (mg/dl) 111.8  58.7 110  69 0.78
Total calcium score 108  260 345  593 <0.001
eGFR (ml/min/1.73 m2) 85  21 85  17 0.52
Framingham risk score 0.06  0.04 0.13  0.07 <0.001
LV end-diastolic volume index (ml/m2) 61.7  11.2 68.3  14.7 <0.001
LV end-systolic volume index (ml/m2) 22.2  5.9 27.3  8.2 <0.001
LV mass index (g/m2) 68.2  2.6 82.9  2.5 <0.001
LV stroke volume index (ml/m2) 39.5  7.7 40.9  9.3 0.003
LV ejection fraction (%) 64.1  6.2 60.2  6.7 <0.001
LV mass-to-volume ratio (g/ml) 0.96  0.19 1.08  0.24 <0.001
Partition coefﬁcient 0.46  0.04 0.44  0.04 <0.001
Pre-contrast myocardial T1 (ms) 986  45 968  38 <0.001
Post-contrast myocardial T1 (ms)
12-min 442  42 471  33 <0.001
25-min 505  41 535  34 <0.001
DT1/Dt (ms/min)y 4.84  1.31 4.79  1.30 0.51
Hematocrit (%)z 38.4  2.9 41.6  3.5 <0.001
Extracellular volume fraction (%)z 28.1  2.8 25.8  2.9 <0.001
Values are mean SD, %, or n (%). *Deﬁned according to National Cholesterol Education Program guidelines. yDT1/Dt ¼ T1 changes per min between
12 and 25 min after contrast. zn ¼ 321 for women; n ¼ 287 for men.
BMI ¼ body mass index; eGFR ¼ estimated glomerular ﬁltration rate; HDL ¼ high-density lipoprotein; LDL ¼ low-density lipoprotein; LV ¼ left
ventricular.
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1283of ECV for a subset of the MESA participants, we found
that sex differences were further ampliﬁed because women
had lower hematocrit levels compared with men (Table 1).
Furthermore, hematocrit was also inversely related to age (in
all participants, univariable regression coefﬁcient B ¼ –2.11
per 10 years; p ¼ 0.034). Altogether, these factors made the
age dependence of ECV stronger than that of partition
coefﬁcients. Indeed, women had higher ECV than men in
all age categories.
For the relationship of age with T1 indices, Table 3
displays the regression coefﬁcients (B) derived from multi-
variate linear regression analyses stratiﬁed according to sex.
Age was signiﬁcantly associated with T1 indices for men in
all adjusted models. The partition coefﬁcient, pre-contrast
T1 times, and ECV were positively correlated with age.
Moreover, post-contrast T1 times and Gd clearance rate
DT1/Dt decreased with age among male MESA partici-
pants. For women, Gd clearance rate DT1/Dt also decreasedwith age in all models, and ECV also decreased with age in
the adjusted models (p ¼ 0.03 and 0.01 in models 2 and 3,
respectively). Figure 2 displays the regression plot between
age and ECV for the entire cohort after adjustment for all
covariables in model 3. ECV increased with age, and there
were no differences of T1 indices among different ethnicities
with the same trend for age dependence for all race/ethnic
categories.
The age dependence of T1 indices was also examined in
the subcohort of MESA participants with a BMI between
18 and 30 kg/m2, who were never smokers, and had no
history of hypertension or diabetes; 92 women and 143 men
were included in this subanalysis. In this subgroup of
participants without risk factors, the mean BMI was 25  4
kg/m2, and their mean age was slightly less than for the full
cohort (65  8 and 67  9 years; p < 0.0001). The partition
coefﬁcient and ECV did not differ between men and women
in this subgroup, but after adjustment for race, body weight,
Table 2 T1 Indices in Each Age Category
54–63 Years 64–73 Years 74–83 Years 84 Years p Trend
Partition coefﬁcient Women 0.455  0.039 0.454  0.042 0.457  0.044 0.465  0.025 0.36
Men 0.436  0.035* 0.442  0.039* 0.457  0.044 0.473  0.039 <0.001
Pre-contrast myocardial T1 (ms) Women 984.4  42.7 984.6  46.5 988.9  47.5 988.4  45.3 0.38
Men 962.1  36.7* 969.0  35.4* 973.1  43.4* 985.7  31.9 <0.001
12-min post-contrast myocardial T1 (ms) Women 441.9  41.1 442.3  43.2 442.4  42.1 440.5  40.6 0.986
Men 475.2  30.8* 471.3  31.7* 467.7  37.4* 454.9  31.7 0.001
25-min post-contrast myocardial T1 (ms) Women 507.0  42.3 505.3  41.6 503.1  41.1 500.5  35.6 0.30
Men 540.9  33.0* 534.2  32.8* 528.2  36.7* 512.4  31.2 <0.001
DT1/Dt (ms/min) Women 5.02  1.33 4.80  1.32 4.60  1.22 4.52  1.25 0.001
Men 4.96  1.17 4.74  1.20 4.64  1.17 4.29  1.44 0.002
Extracellular volume fraction (%) Women 27.80  2.47 28.04  3.00 28.24  3.06 29.19  1.83 0.071
Men 25.19  2.52* 25.55  2.57* 26.52  3.14* 28.28  3.58 <0.001
Values are mean  SD. *p < 0.05 between women and men in that age category.
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(p ¼ 0.005) and the Gd clearance rate (p ¼ 0.03) remained
signiﬁcantly correlated with age in women.Discussion
Myocardial ﬁbrosis is commonly found in association with
cardiac hypertrophy and failure, and it is associated with
worsening ventricular systolic function, abnormal cardiac
remodeling, and increased ventricular stiffness in animal
models (9,11,29). Although endomyocardial biopsy is the
most speciﬁc procedure for measuring myocardial ﬁbrosis,
it is invasive, and its sensitivity is low due to sampling
error (30). In the current study, we evaluated myocardial
tissue composition by using CMR T1 mapping in a large
multiethnic, population-based study. Our results foundFigure 1 Partition Coefﬁcient and ECV in Age Categories
The mean (A) partition coefﬁcient and (B) extracellular volume (ECV) fraction in each agea consistent speciﬁc correlation between T1 indices and age.
All CMR indices in men indicated a higher degree of diffuse
myocardial ﬁbrosis with greater age, but in women, similar
relations were only found in models fully adjusted for
cardiovascular risk factors and markers of subclinical
cardiovascular diseases.
Previous studies have focused on volunteers and patients
with cardiac diseases. Among these, Ugander et al. (26) re-
cruited 60 patients between age 20 and 80 years with
cardiovascular disease but without abnormalities on late Gd
enhancement images. They found a signiﬁcant correlation
between age and ECV in these subjects. A study conducted
by Schelbert et al. (25) also showed signiﬁcantly increased
ECV with age in 10 volunteers with a wide age range (20 to
81 years). Pre-contrast T1 mapping has gained attention
recently because it is obviously easier to perform. Noncontrastcategory stratiﬁed according to sex. *p < 0.05 between women and men.
Table 3 Regression Models for Association of T1 Indices With Age Across Sex (Regression Coefﬁcients B/p Value)
Model 1 Model 2 Model 3
B p Value B p Value B p Value
Partition coefﬁcient Women 0.001 0.958 0.001 0.601 0.001 0.504
Men 0.01 <0.001 0.01 <0.001 0.01 <0.001
Pre-contrast myocardial T1 (ms) Women 2.8 0.19 2.81 0.231 4.36 0.087
Men 6.49 <0.001 5.74 0.004 4.83 0.018
12-min post-contrast myocardial T1 (ms) Women 1.21 0.508 1.69 0.391 2.2 0.304
Men 5.32 0.001 4.69 0.004 4.17 0.013
25-min post-contrast myocardial T1 (ms) Women 3.61 0.044 1.19 0.534 0.37 0.585
Men 7.88 <0.001 6.67 <0.001 6.28 0.001
DT1/Dt (ms/min) Women 0.2 0.001 0.22 0.001 0.19 0.012
Men 0.18 0.004 0.17 0.016 0.19 0.007
Extracellular volume fraction (%) Women 0.16 0.379 0.39 0.048 0.49 0.023
Men 0.91 <0.001 1.15 <0.001 1.04 <0.001
Model 1 ¼ multivariable analysis accounting for race/ethnicity, weight, and heart rate; Model 2 ¼ adjusted for the variables in model 1 in addition to systolic blood pressure, estimated glomerular ﬁltration
rate, and current smoking status; Model 3 ¼ adjusted for the variables in model 2 in addition to smoking pack years, diabetes mellitus, taking medication for hypertension, low-density lipoprotein, high-
density lipoprotein, left ventricular mass-to-volume ratio, and education (highest level completed).
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1285T1 mapping was able to assess the extent of myocardial
damage in acute infarction (31) and to detect acute myocar-
dial edema with high diagnostic accuracy compared with
conventional T2-weighted sequences (32). Age-associated
changes of pre-contrast T1 values have also been examined
in 231 normal controls (age 11 to 85 years) (33) in which pre-
contrast T1 decreased slightly with age but with large varia-
tions probably secondary to small sample sizes within each
age group. In addition, the investigators demonstrated higher
pre-contrast T1 in women than in men, which was consistent
with our results. The MESA participants in our study were
older and were not volunteers, having been selected for
participation as part of a population-based design; hence,
a direct comparison is difﬁcult.Figure 2 Associations Between Age and ECV
Regression plot between age and extracellular volume fraction (ECV) in all cohorts
after adjustments for all covariables in model 3.Our data demonstrated a stronger age dependence of the
T1 indices in men than in women. The associations in men
remained signiﬁcant after adjustments for demographic
characteristics, estimated GFR, cardiovascular risk factors,
and cardiac function, including the LV mass-to-volume
ratio. However, in women, only the Gd clearance rate
DT1/Dt (all models) and ECV (adjusted models) showed
signiﬁcant correlations with age. It is widely recognized that
male and female hearts are different in structure and func-
tion as well as in response to numerous stimuli (34,35).
Olivetti et al. (36) investigated the changes in myocyte size
and number that occur with aging in human hearts. They
showed that myocyte cell loss and cellular reactive hyper-
trophy were greater in the senescent male heart, but the
number and size of myocytes of the female heart were not
altered in the aging process. Female hearts demonstrated
better preservation of myocardial structure with aging. These
pathological examinations in autopsies conﬁrmed our sex-
speciﬁc difference in the age dependence of the T1 indices.
In addition, LV mass is lower in older men compared with
younger men, as shown by CMR (37); this relationship to
age is less pronounced in women. The current study extends
these observations, suggesting that increased extracellular
space becomes more pronounced in older men.
Sex interactions with cardiovascular risk vary with age,
and women outnumber men in cardiovascular death rates by
20% after age 65 years (38). In general, male hearts respond
less well to pressure or volume overload, to myocardial
infarction, and to aging (34). However, it is also notable
that women are approximately twice as likely as men to
develop heart failure with preserved LV ejection fraction
(39,40). In our data, partition coefﬁcients as well as ECV
were all greater for women than men. Sado et al. (41)
measured ECV by using CMR methods in 81 normal
volunteers (median age 43 years; age range 24 to 81 years)
and found higher ECV in women than in men. One of the
possible explanations suggested in the paper was that the
Liu et al. JACC Vol. 62, No. 14, 2013
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1286partial volume effects due to the consequence of their
measurement techniques (CINE-IR) in the hearts of
thinner women could potentially lead to higher ECV. Our
study implemented the T1-mapping techniques with higher
resolution and gated at the end-diastolic cardiac phase. T1
measurements were carefully restricted to the core myocar-
dium to avoid partial voluming at the wall–blood borders.
Using our data, univariate analysis showed that the partition
coefﬁcient was inversely correlated to myocardial wall
thickness (p ¼ 0.001), but this correlation disappeared after
adjustment for age and sex (p ¼ 0.12). Unlike the direct
evidence of age association differences in myocardial struc-
ture between women and men, to the best of our knowledge,
there are no previous population-based studies documenting
sex differences in the cardiac extracellular space, particularly
involving individuals of diverse race and ethnicity.
For the subgroup of “healthy” participants with reduced
exposure to cardiovascular risk factors in our cohort (never
smokers, no hypertension, no diabetes, and normal BMI
[among other factors]), there was no ECV differences
between women and men. As shown in Figure 1, the
difference between sexes diminished with age. Compared
with the study by Sado et al. (41), our study population was
older; hence, a larger sample size might be required to show
statistical differences between sexes. Second, there was no
correlation between age and myocardial ECV, which is
consistent with their ﬁndings. We note that the sample size
of this healthier cohort is smaller, and we risk emphasizing
certain characteristics in this selection process compared
with a more general model in which risk factors are included
as model covariates. However, we also cannot exclude the
possibility that there is a sex-speciﬁc response to myocyte
cell loss and cellular reactive hypertrophy in diseased hearts,
although such difference is minimal in healthy hearts.
Our study also demonstrated higher ejection fractions in
women than in men, in agreement with previous reports in
a community-based multiethnic study (37). The ejection
fractions in the participants of the current study were
mostly normal; only 3.6% (n ¼ 45) had ejection
fractions <50%. There was no difference in all T1 indices
between groups with ejection fractions >50% and <50%
even after adjustment for age, sex, and race. Hence, the
relation of heart failure to T1 indices cannot be inferred from
our study.
Although T1 mapping has gained in popularity and
availability in clinical CMR settings, the diagnostic potential
of this technique in speciﬁc patient groups requires further
elucidation. One of the key factors for the differentiation
between normal and pathological states is the range of the
normal T1 values as well as the ECV. For example, in
normal subjects ages 20 to 40 years, the observed range of
ECV values (0.22 to 0.32) was relatively large (42). Never-
theless, CMR T1 mapping was able to discriminate between
normal subjects and patients with cardiomyopathy and
ﬁbrosis by using endomyocardial biopsy and no myocardial
scar by using CMR (43).Study limitations. Our data indicate that age and sex
should be taken into consideration when comparing T1
indices cross-sectionally. Based on ample multiethnic pop-
ulation sizes, our results provide the distribution of expected
T1 indices categorized by age and sex in a population of
apparently normal older individuals. A limitation of the T1
CMR methods is that these indices may vary depending on
the MRI technique, ﬁeld strength, Gd contrast agent, and
dose used for the T1 measurement (42,44–47). The partition
coefﬁcient and ECV account for blood T1 that should be
robust against some of the aforementioned sources of vari-
ation, but multiple measurements are required. The gener-
alization of our results may be limited due to the nature of
the cross-sectional design; as such, there is a bias toward
including in the study individuals with more favorable
survivorship. Our study also did not include persons <54
years of age. Finally, the effects of age on the cardiovascular
system are probably inseparable from multifactorial events
accumulated over a lifetime, including both known and
unknown factors that affect the myocardium.
Conclusions
Our study documents a systematic analysis of the distribu-
tion of in vivo measurements of myocardial T1 indices ob-
tained with clinical 1.5-T MR systems. CMR parameters
that are associated with ﬁbrosis in experimental models were
related to older age in the MESA study after taking into
account demographic characteristics and cardiovascular risk
factors. These indices of interstitial myocardial ﬁbrosis
suggest greater age-related changes in men than in women.
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